August 15 - 18
Grand Hyatt Washington, Washington, D.C.
Flagship scientists presented two posters at the Next Generation Dx Summit. Follow the links below to see the full posters.
- MULTIPARAMETRIC IMMUNOHISTOCHEMISTRY QUANTIFICATION WITH COMPUTATIONAL TISSUE ANALYSIS FOR TUMOR IMMUNE PROFILING
- EVALUATING IMAGE ANALYSIS APPROACHES TOWARD "HARMONIZATION" OF PD-L1 ASSAYS
Meet with Flagship at the Next Generation Dx Summit 2017 to discover how we help drug developers define their path to success. Our computational Tissue Analysis (cTA™) approach provides the quantitative, contextual data needed to make confident clinical trials decisions. We partner with drug developers to implement tissue-based biomarker strategies and drive efficient and effective clinical trials.
Look for our booth, #415, at this important conference to discuss your needs in clinical trial decision support.